The prion protein has DNA strand transfer properties similar to retroviral nucleocapsid protein.
暂无分享,去创建一个
C. Péchoux | C. Gabus | W. Surewicz | J. Darlix | D. Dormont | W. Swietnicki | M. Morillas | P. Nandi | S. Auxilien
[1] E. Stadtman,et al. Regulation of glutamine synthetase. XII. Electron microscopy of the enzyme from Escherichia coli. , 1968, Biochemistry.
[2] S. Prusiner. Novel proteinaceous infectious particles cause scrapie. , 1982, Science.
[3] F. Barré-Sinoussi,et al. HIV‐1 reverse transcriptase specifically interacts with the anticodon domain of its cognate primer tRNA. , 1989, The EMBO journal.
[4] T. Sklaviadis,et al. Potential retroviral RNAs in Creutzfeldt-Jakob disease , 1990, Journal of virology.
[5] Stephen J. DeArmond,et al. Transgenetic studies implicate interactions between homologous PrP isoforms in scrapie prion replication , 1990, Cell.
[6] R. Young,et al. Mutations of RNA and protein sequences involved in human immunodeficiency virus type 1 packaging result in production of noninfectious virus , 1990, Journal of virology.
[7] S. Prusiner,et al. Acquisition of protease resistance by prion proteins in scrapie-infected cells does not require asparagine-linked glycosylation. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[8] B. Chesebro,et al. Normal and scrapie-associated forms of prion protein differ in their sensitivities to phospholipase and proteases in intact neuroblastoma cells , 1990, Journal of virology.
[9] G. J. Raymond,et al. The scrapie-associated form of PrP is made from a cell surface precursor that is both protease- and phospholipase-sensitive. , 1991, The Journal of biological chemistry.
[10] B. Roques,et al. Viral RNA annealing activities of human immunodeficiency virus type 1 nucleocapsid protein require only peptide domains outside the zinc fingers. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[11] S. Bratosin-Guttman. A new method for the routine spreading of DNA in protein-free conditions. , 1992, Journal of structural biology.
[12] A. Aguzzi,et al. Mice devoid of PrP are resistant to scrapie , 1993, Cell.
[13] B. Roques,et al. Trans-activation of the 5' to 3' viral DNA strand transfer by nucleocapsid protein during reverse transcription of HIV1 RNA. , 1993, Comptes rendus de l'Academie des sciences. Serie III, Sciences de la vie.
[14] T. Sklaviadis,et al. Nucleic acid binding proteins in highly purified Creutzfeldt-Jakob disease preparations. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[15] U. Ramsperger,et al. p53‐catalyzed annealing of complementary single‐stranded nucleic acids. , 1993, The EMBO journal.
[16] C. Burd,et al. Conserved structures and diversity of functions of RNA-binding proteins. , 1994, Science.
[17] G. J. Raymond,et al. Binding of the protease-sensitive form of PrP (prion protein) to sulfated glycosaminoglycan and congo red [corrected] , 1994, Journal of virology.
[18] J. Darlix,et al. Transactivation of the minus‐strand DNA transfer by nucleocapsid protein during reverse transcription of the retroviral genome. , 1994, The EMBO journal.
[19] Douglas S. Portman,et al. RNA annealing activities in HeLa nuclei. , 1994, The EMBO journal.
[20] A. Akowitz,et al. Endogenous viral complexes with long RNA cosediment with the agent of Creutzfeldt-Jakob disease. , 1994, Nucleic acids research.
[21] D. Herschlag. RNA Chaperones and the RNA Folding Problem (*) , 1995, The Journal of Biological Chemistry.
[22] A. Akowitz,et al. Viral particles are required for infection in neurodegenerative Creutzfeldt-Jakob disease. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[23] B. Roques,et al. First glimpses at structure-function relationships of the nucleocapsid protein of retroviruses. , 1995, Journal of molecular biology.
[24] Mary Lapadat-Tapolsky,et al. Analysis of the nucleic acid annealing activities of nucleocapsid protein from HIV-1 , 1995, Nucleic Acids Res..
[25] T. Formosa,et al. Yeast Proteins Related to the p40/Laminin Receptor Precursor Are Essential Components of the 40 S Ribosomal Subunit (*) , 1996, The Journal of Biological Chemistry.
[26] C. Gabus,et al. Possible roles of HIV-1 nucleocapsid protein in the specificity of proviral DNA synthesis and in its variability. , 1997, Journal of molecular biology.
[27] J. Mak,et al. Primer tRNAs for reverse transcription , 1997, Journal of virology.
[28] P E Wright,et al. Structure of the recombinant full-length hamster prion protein PrP(29-231): the N terminus is highly flexible. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[29] J. Loike,et al. Mac-1 (CD11b/CD18) is an oligodeoxynucleotide-binding protein , 1997, Nature Medicine.
[30] F. Edenhofer,et al. The human 37-kDa laminin receptor precursor interacts with the prion protein in eukaryotic cells , 1997, Nature Medicine.
[31] G. Pesole,et al. The 67-kDa laminin receptor originated from a ribosomal protein that acquired a dual function during evolution. , 1998, Molecular biology and evolution.
[32] S. Prusiner,et al. A transmembrane form of the prion protein in neurodegenerative disease. , 1998, Science.
[33] D. Ficheux,et al. The yeast Ty3 retrotransposon contains a 5′–3′ bipartite primer‐binding site and encodes nucleocapsid protein NCp9 functionally homologous to HIV‐1 NCp7 , 1998, The EMBO journal.
[34] S. Dupuis,et al. Telomere elongation by hnRNP A1 and a derivative that interacts with telomeric repeats and telomerase , 1998, Nature Genetics.
[35] S. Hornemann,et al. Prion protein expression in different species: analysis with a panel of new mAbs. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[36] F. Cohen,et al. Prion Protein Biology , 1998, Cell.
[37] S. L. Le Grice,et al. Role of Post-transcriptional Modifications of Primer tRNALys,3 in the Fidelity and Efficacy of Plus Strand DNA Transfer during HIV-1 Reverse Transcription* , 1999, The Journal of Biological Chemistry.
[38] R. Carp,et al. Scrapie strain-specific interactions with endogenous murine leukaemia virus. , 1999, The Journal of general virology.
[39] S. Ferrari,et al. Proteasomal Degradation and N-terminal Protease Resistance of the Codon 145 Mutant Prion Protein* , 1999, The Journal of Biological Chemistry.
[40] J. Brockes. Topics in prion cell biology , 1999, Current Opinion in Neurobiology.
[41] W. Surewicz,et al. Membrane Environment Alters the Conformational Structure of the Recombinant Human Prion Protein* , 1999, The Journal of Biological Chemistry.
[42] J. Bess,et al. Molecular Requirements for Human Immunodeficiency Virus Type 1 Plus-Strand Transfer: Analysis in Reconstituted and Endogenous Reverse Transcription Systems , 1999, Journal of Virology.
[43] J. Luban,et al. Basic Residues in Human Immunodeficiency Virus Type 1 Nucleocapsid Promote Virion Assembly via Interaction with RNA , 2000, Journal of Virology.
[44] Toshiko Tanaka,et al. A Human Gene Coding for a Membrane-associated Nucleic Acid-binding Protein* , 2000, The Journal of Biological Chemistry.
[45] J. Laplanche,et al. Signal transduction through prion protein. , 2000, Science.
[46] K Wüthrich,et al. NMR solution structure of the human prion protein. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[47] Jianhui Guo,et al. Zinc Finger Structures in the Human Immunodeficiency Virus Type 1 Nucleocapsid Protein Facilitate Efficient Minus- and Plus-Strand Transfer , 2000, Journal of Virology.
[48] C. Gabus,et al. The Prion Protein Has RNA Binding and Chaperoning Properties Characteristic of Nucleocapsid Protein NCp7 of HIV-1* , 2001, The Journal of Biological Chemistry.